170 related articles for article (PubMed ID: 34517345)
1. TNFSF9 promotes metastasis of pancreatic cancer through Wnt/Snail signaling and M2 polarization of macrophages.
Wu J; Wang Y; Yang Y; Liu F; Chen J; Jiang Z; Jiang Z
Aging (Albany NY); 2021 Sep; 13(17):21571-21586. PubMed ID: 34517345
[TBL] [Abstract][Full Text] [Related]
2. TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through Src/FAK/p-Akt/IL-1β signaling.
Wu J; Wang Y; Yang Y; Liu F; Jiang Z; Jiang Z
Int Immunopharmacol; 2022 Jan; 102():108429. PubMed ID: 34906856
[TBL] [Abstract][Full Text] [Related]
3. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
4. Autoinducer-2 of Fusobacterium nucleatum promotes macrophage M1 polarization via TNFSF9/IL-1β signaling.
Wu J; Li K; Peng W; Li H; Li Q; Wang X; Peng Y; Tang X; Fu X
Int Immunopharmacol; 2019 Sep; 74():105724. PubMed ID: 31272064
[TBL] [Abstract][Full Text] [Related]
5. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype.
Zhang F; Wang H; Wang X; Jiang G; Liu H; Zhang G; Wang H; Fang R; Bu X; Cai S; Du J
Oncotarget; 2016 Aug; 7(32):52294-52306. PubMed ID: 27418133
[TBL] [Abstract][Full Text] [Related]
6. TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition.
Zhou B; Zhan H; Tin L; Liu S; Xu J; Dong Y; Li X; Wu L; Guo W
Cancer Lett; 2016 Nov; 382(1):11-20. PubMed ID: 27566398
[TBL] [Abstract][Full Text] [Related]
7. TNFSF9 exerts an inhibitory effect on hepatocellular carcinoma.
Shen YL; Gan Y; Gao HF; Fan YC; Wang Q; Yuan H; Song YF; Wang JD; Tu H
J Dig Dis; 2017 Jul; 18(7):395-403. PubMed ID: 28547807
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
9. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.
Wu J; Wang Y; Jiang Z
J Gastrointest Cancer; 2021 Mar; 52(1):150-159. PubMed ID: 32077004
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
[TBL] [Abstract][Full Text] [Related]
11. Linc00261 inhibits metastasis and the WNT signaling pathway of pancreatic cancer by regulating a miR‑552‑5p/FOXO3 axis.
Chen T; Lei S; Zeng Z; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Oncol Rep; 2020 Mar; 43(3):930-942. PubMed ID: 32020223
[TBL] [Abstract][Full Text] [Related]
12. Kindlin-2 induced by TGF-β signaling promotes pancreatic ductal adenocarcinoma progression through downregulation of transcriptional factor HOXB9.
Zhan J; Song J; Wang P; Chi X; Wang Y; Guo Y; Fang W; Zhang H
Cancer Lett; 2015 May; 361(1):75-85. PubMed ID: 25724625
[TBL] [Abstract][Full Text] [Related]
13. TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells.
He R; Wang M; Zhao C; Shen M; Yu Y; He L; Zhao Y; Chen H; Shi X; Zhou M; Pan S; Liu Y; Guo X; Li X; Qin R
J Exp Clin Cancer Res; 2019 Aug; 38(1):340. PubMed ID: 31387632
[TBL] [Abstract][Full Text] [Related]
14. Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner.
Ren R; Yu J; Zhang Y; Wang SF; Guo X; Shen M; Xu MD; Jiang M; Zhi Q; Chen K; Tao M; Wu MY; Gu DM; Li W
Pancreas; 2019 Sep; 48(8):1003-1014. PubMed ID: 31404031
[TBL] [Abstract][Full Text] [Related]
15. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo.
Liu N; Ma M; Qu N; Wang R; Chen H; Hu F; Gao S; Shan F
Int Immunopharmacol; 2020 Sep; 86():106718. PubMed ID: 32585612
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer.
Bai L; Liang J; Li L; Li E
Oncol Rep; 2020 Apr; 43(4):1208-1220. PubMed ID: 32323835
[TBL] [Abstract][Full Text] [Related]
17. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway.
Li F; Dai L; Niu J
J Cell Physiol; 2020 Nov; 235(11):7780-7790. PubMed ID: 31774184
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.
Wei F; Ding L; Wei Z; Zhang Y; Li Y; Qinghua L; Ma Y; Guo L; Lv G; Liu Y
Oncotarget; 2016 Dec; 7(51):85259-85272. PubMed ID: 27845896
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
Yang HW; Liu GH; Liu YQ; Zhao HC; Yang Z; Zhao CL; Zhang XF; Ye H
Biomed Pharmacother; 2016 Oct; 83():593-601. PubMed ID: 27459115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
